Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17.08 Billion CNY | 16.96% |
| 2022 | 14.6 Billion CNY | 16.87% |
| 2021 | 12.49 Billion CNY | 22.44% |
| 2020 | 10.2 Billion CNY | 15.83% |
| 2019 | 8.81 Billion CNY | 32.34% |
| 2018 | 6.65 Billion CNY | 17.87% |
| 2017 | 5.64 Billion CNY | 12.12% |
| 2016 | 5.03 Billion CNY | 24.24% |
| 2015 | 4.05 Billion CNY | 11.1% |
| 2014 | 3.64 Billion CNY | 11.98% |
| 2013 | 3.25 Billion CNY | 46.11% |
| 2012 | 2.23 Billion CNY | 42.21% |
| 2011 | 1.56 Billion CNY | 8.42% |
| 2010 | 1.44 Billion CNY | 12.63% |
| 2009 | 1.28 Billion CNY | 19.99% |
| 2008 | 1.07 Billion CNY | 10.27% |
| 2007 | 970.87 Million CNY | 32.88% |
| 2006 | 730.61 Million CNY | 5.33% |
| 2005 | 693.62 Million CNY | 24.13% |
| 2004 | 558.77 Million CNY | -6.09% |
| 2003 | 594.98 Million CNY | 82.63% |
| 2002 | 325.79 Million CNY | 20.5% |
| 2001 | 270.36 Million CNY | 4.52% |
| 2000 | 258.67 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 18.29 Billion CNY | 7.11% |
| 2024 Q2 | 17.04 Billion CNY | -6.82% |
| 2024 Q3 | 17.98 Billion CNY | 5.52% |
| 2023 FY | 17.08 Billion CNY | 16.96% |
| 2023 Q3 | 16.09 Billion CNY | 1.18% |
| 2023 Q4 | 17.08 Billion CNY | 6.12% |
| 2023 Q1 | 15.06 Billion CNY | 3.18% |
| 2023 Q2 | 15.9 Billion CNY | 5.57% |
| 2022 Q3 | 13.51 Billion CNY | -0.23% |
| 2022 Q4 | 14.6 Billion CNY | 8.07% |
| 2022 FY | 14.6 Billion CNY | 16.87% |
| 2022 Q1 | 12.87 Billion CNY | 3.03% |
| 2022 Q2 | 13.54 Billion CNY | 5.22% |
| 2021 Q2 | 10.93 Billion CNY | -0.17% |
| 2021 Q1 | 10.95 Billion CNY | 7.37% |
| 2021 FY | 12.49 Billion CNY | 22.44% |
| 2021 Q4 | 12.49 Billion CNY | 4.32% |
| 2021 Q3 | 11.97 Billion CNY | 9.51% |
| 2020 Q1 | 9.22 Billion CNY | 4.65% |
| 2020 FY | 10.2 Billion CNY | 15.83% |
| 2020 Q2 | 9.02 Billion CNY | -2.08% |
| 2020 Q4 | 10.2 Billion CNY | 0.83% |
| 2020 Q3 | 10.12 Billion CNY | 12.1% |
| 2019 Q1 | 7.36 Billion CNY | 10.65% |
| 2019 Q3 | 8.42 Billion CNY | 6.2% |
| 2019 Q4 | 8.81 Billion CNY | 4.55% |
| 2019 FY | 8.81 Billion CNY | 32.34% |
| 2019 Q2 | 7.93 Billion CNY | 7.72% |
| 2018 Q4 | 6.65 Billion CNY | 3.51% |
| 2018 Q3 | 6.43 Billion CNY | 5.35% |
| 2018 Q2 | 6.1 Billion CNY | 0.38% |
| 2018 Q1 | 6.08 Billion CNY | 7.67% |
| 2018 FY | 6.65 Billion CNY | 17.87% |
| 2017 Q4 | 5.64 Billion CNY | 2.94% |
| 2017 Q2 | 4.99 Billion CNY | -1.0% |
| 2017 Q1 | 5.04 Billion CNY | 0.17% |
| 2017 FY | 5.64 Billion CNY | 12.12% |
| 2017 Q3 | 5.48 Billion CNY | 9.83% |
| 2016 Q4 | 5.03 Billion CNY | 7.23% |
| 2016 Q3 | 4.69 Billion CNY | 10.46% |
| 2016 FY | 5.03 Billion CNY | 24.24% |
| 2016 Q2 | 4.25 Billion CNY | -1.72% |
| 2016 Q1 | 4.32 Billion CNY | 6.73% |
| 2015 Q1 | 3.77 Billion CNY | 3.39% |
| 2015 FY | 4.05 Billion CNY | 11.1% |
| 2015 Q2 | 3.75 Billion CNY | -0.4% |
| 2015 Q4 | 4.05 Billion CNY | 6.5% |
| 2015 Q3 | 3.8 Billion CNY | 1.32% |
| 2014 Q2 | 3.2 Billion CNY | -3.73% |
| 2014 FY | 3.64 Billion CNY | 11.98% |
| 2014 Q1 | 3.32 Billion CNY | 2.1% |
| 2014 Q4 | 3.64 Billion CNY | 7.78% |
| 2014 Q3 | 3.38 Billion CNY | 5.7% |
| 2013 Q1 | 2.37 Billion CNY | 6.66% |
| 2013 Q2 | 2.38 Billion CNY | 0.39% |
| 2013 Q3 | 3.24 Billion CNY | 35.81% |
| 2013 FY | 3.25 Billion CNY | 46.11% |
| 2013 Q4 | 3.25 Billion CNY | 0.47% |
| 2012 FY | 2.23 Billion CNY | 42.21% |
| 2012 Q3 | 2.1 Billion CNY | 9.43% |
| 2012 Q2 | 1.92 Billion CNY | -0.77% |
| 2012 Q1 | 1.94 Billion CNY | 23.75% |
| 2012 Q4 | 2.23 Billion CNY | 5.82% |
| 2011 FY | 1.56 Billion CNY | 8.42% |
| 2011 Q4 | 1.56 Billion CNY | 0.63% |
| 2011 Q1 | 1.52 Billion CNY | 5.16% |
| 2011 Q2 | 1.53 Billion CNY | 1.2% |
| 2011 Q3 | 1.55 Billion CNY | 1.25% |
| 2010 Q3 | 1.32 Billion CNY | 5.23% |
| 2010 FY | 1.44 Billion CNY | 12.63% |
| 2010 Q4 | 1.44 Billion CNY | 8.97% |
| 2010 Q1 | 1.34 Billion CNY | 4.98% |
| 2010 Q2 | 1.26 Billion CNY | -6.43% |
| 2009 FY | 1.28 Billion CNY | 19.99% |
| 2009 Q1 | 1.1 Billion CNY | 3.27% |
| 2009 Q2 | 1.14 Billion CNY | 3.63% |
| 2009 Q3 | 1.2 Billion CNY | 5.32% |
| 2009 Q4 | 1.28 Billion CNY | 6.46% |
| 2008 FY | 1.07 Billion CNY | 10.27% |
| 2008 Q1 | 980.35 Million CNY | 0.98% |
| 2008 Q2 | 988.07 Million CNY | 0.79% |
| 2008 Q4 | 1.07 Billion CNY | 4.24% |
| 2008 Q3 | 1.02 Billion CNY | 3.94% |
| 2007 Q4 | 970.87 Million CNY | 17.7% |
| 2007 Q3 | 824.9 Million CNY | 3.72% |
| 2007 Q2 | 795.33 Million CNY | 5.74% |
| 2007 Q1 | 752.12 Million CNY | 2.94% |
| 2007 FY | 970.87 Million CNY | 32.88% |
| 2006 Q2 | 676.36 Million CNY | -6.44% |
| 2006 Q3 | 700.3 Million CNY | 3.54% |
| 2006 Q4 | 730.61 Million CNY | 4.33% |
| 2006 FY | 730.61 Million CNY | 5.33% |
| 2006 Q1 | 722.92 Million CNY | 4.22% |
| 2005 Q3 | 697.59 Million CNY | 6.01% |
| 2005 Q2 | 658.04 Million CNY | 15.35% |
| 2005 Q1 | 570.47 Million CNY | 2.09% |
| 2005 FY | 693.62 Million CNY | 24.13% |
| 2005 Q4 | 693.62 Million CNY | -0.57% |
| 2004 Q3 | 583.83 Million CNY | 2.52% |
| 2004 Q1 | 593.3 Million CNY | -0.28% |
| 2004 Q2 | 569.5 Million CNY | -4.01% |
| 2004 FY | 558.77 Million CNY | -6.09% |
| 2004 Q4 | 558.77 Million CNY | -4.29% |
| 2003 Q3 | 560.37 Million CNY | -3.99% |
| 2003 Q2 | 583.68 Million CNY | 0.0% |
| 2003 FY | 594.98 Million CNY | 82.63% |
| 2003 Q4 | 594.98 Million CNY | 6.18% |
| 2002 Q4 | 325.79 Million CNY | 0.0% |
| 2002 FY | 325.79 Million CNY | 20.5% |
| 2001 FY | 270.36 Million CNY | 4.52% |
| 2000 FY | 258.67 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 43.78 Billion CNY | 60.99% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 11.23 Billion CNY | -51.985% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 3.27 Billion CNY | -420.85% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | -685.695% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 346.28 Million CNY | -4832.422% |
| NanJing Pharmaceutical Company Limited | 28.5 Billion CNY | 40.089% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | -549.837% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 7.77 Billion CNY | -119.786% |